Success Case of the Application of Virtual High Throughput Screening Against Molecular Antimalarial Targets
Referências
1. Lamikanra, A. A. et al. Blood 110, 18–28 (2007).
2. Leite, F. H. A. et al. BBR - Biochem. Biotechnol. Reports 2, 59 (2013).
3. Ferreira, M. U., M. D. S.-N. & Silva-Nunes, M. Da. Journal of Infection in Developing Countries 4, 533–545 (2010).
4. Sahu, N. K., Sahu, S. & Kohli, D. V. Chem. Biol. Drug Des. 71, 287–297 (2008).
5. Melo, G. C. et al. PLoS One. 9, e105922 (2014).
6. Bordoli, L. et al. Nat. Protoc. 4, 1–13 (2009).
7. Trott, O. & Olson, A. J. J. Comput. Chem. 31, 455–461 (2010).
8. Fonseca. A. L., Nunes. R. R., Ricardo José Alves. R. J. et al. BBR - Biochem. Biotechnol. Reports 2, 111–113 (2013).
9. Westermaier, Y., Barril, X. & Scapozza, L. Methods 71, 44–57 (2015).
10. Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S. & Coleman, R. G. Journal of Chemical Information and Modeling (2012).
11. Andricopulo, A. & Ferreira, L. Medicinal. J. Mod. Med. Chem. 2, 20–31 (2014).
12. Carregal, A. P., Jr, M. C. & Taranto., A. G. BBR - Biochem. Biotechnol. Reports 2, 14–16 (2013).
13. Berman, H. M. et al. Nucleic Acids Res. 28, 235–242 (2000).
14. De Oliveira, M. E. et al. Molecules 18, 15276–15287 (2013).
15. Guimarães, D. S. M. et al. Mem. Inst. Oswaldo Cruz 110, 255–8 (2015).
16. Kuhn, Y., Rohrbach, P. & Lanzer, M.. Cell. Microbiol. 9, 1004–1013 (2007).
17. Stewart, J.J.P., S. C. C. MOPAC2012. (2012). at
18. Stewart, J. J. P..J. Mol. Model. 19, 1–32 (2013).
19. Salam, N. K., Adzhigirey, M., Sherman, W. & Pearlman, D. A. Protein Eng. Des. Sel. 27, 365–374 (2014).
20. De Magalhães, C. S., Almeida, D. M., Barbosa, H. J. C. & Dardenne, L. E. Inf. Sci. (Ny). 289, 206–224 (2014).
21. Grosdidier, A., Zoete, V. & Michielin, O. Nucleic Acids Res. 39, 270–277 (2011).
22. Jorgensen, W. L. Science 303, 1813–1818 (2004).
2. Leite, F. H. A. et al. BBR - Biochem. Biotechnol. Reports 2, 59 (2013).
3. Ferreira, M. U., M. D. S.-N. & Silva-Nunes, M. Da. Journal of Infection in Developing Countries 4, 533–545 (2010).
4. Sahu, N. K., Sahu, S. & Kohli, D. V. Chem. Biol. Drug Des. 71, 287–297 (2008).
5. Melo, G. C. et al. PLoS One. 9, e105922 (2014).
6. Bordoli, L. et al. Nat. Protoc. 4, 1–13 (2009).
7. Trott, O. & Olson, A. J. J. Comput. Chem. 31, 455–461 (2010).
8. Fonseca. A. L., Nunes. R. R., Ricardo José Alves. R. J. et al. BBR - Biochem. Biotechnol. Reports 2, 111–113 (2013).
9. Westermaier, Y., Barril, X. & Scapozza, L. Methods 71, 44–57 (2015).
10. Irwin, J. J., Sterling, T., Mysinger, M. M., Bolstad, E. S. & Coleman, R. G. Journal of Chemical Information and Modeling (2012).
11. Andricopulo, A. & Ferreira, L. Medicinal. J. Mod. Med. Chem. 2, 20–31 (2014).
12. Carregal, A. P., Jr, M. C. & Taranto., A. G. BBR - Biochem. Biotechnol. Reports 2, 14–16 (2013).
13. Berman, H. M. et al. Nucleic Acids Res. 28, 235–242 (2000).
14. De Oliveira, M. E. et al. Molecules 18, 15276–15287 (2013).
15. Guimarães, D. S. M. et al. Mem. Inst. Oswaldo Cruz 110, 255–8 (2015).
16. Kuhn, Y., Rohrbach, P. & Lanzer, M.. Cell. Microbiol. 9, 1004–1013 (2007).
17. Stewart, J.J.P., S. C. C. MOPAC2012. (2012). at
18. Stewart, J. J. P..J. Mol. Model. 19, 1–32 (2013).
19. Salam, N. K., Adzhigirey, M., Sherman, W. & Pearlman, D. A. Protein Eng. Des. Sel. 27, 365–374 (2014).
20. De Magalhães, C. S., Almeida, D. M., Barbosa, H. J. C. & Dardenne, L. E. Inf. Sci. (Ny). 289, 206–224 (2014).
21. Grosdidier, A., Zoete, V. & Michielin, O. Nucleic Acids Res. 39, 270–277 (2011).
22. Jorgensen, W. L. Science 303, 1813–1818 (2004).
Publicado
2015-07-01
Como Citar
Nunes, R. R., Chagas, R. C. R., Varotti, F. de P., & Taranto, A. G. (2015). Success Case of the Application of Virtual High Throughput Screening Against Molecular Antimalarial Targets. Revista Processos Químicos, 9(18), 202-206. https://doi.org/10.19142/rpq.v9i18.298
Seção
Artigos Gerais
Copyright (c) 2005 Revista Processos Químicos
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.